Free Trial

Phathom Pharmaceuticals (PHAT) SEC Filings & 10K Form

Phathom Pharmaceuticals logo
$4.41 +0.19 (+4.50%)
Closing price 04:00 PM Eastern
Extended Trading
$4.40 0.00 (-0.11%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Phathom Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/06/2025
4:18 PM
Phathom Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:24 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:20 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:05 AM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:05 AM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
10:46 AM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:12 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
11/05/2024
2:32 PM
Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G
11/04/2024
10:20 AM
JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G
08/22/2024
3:05 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
08/19/2024
4:12 PM
Phathom Pharmaceuticals (Filer)
Form 424B5
08/19/2024
4:13 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
5:05 AM
Phathom Pharmaceuticals (Subject)
Form FWP
08/08/2024
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
1:52 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
1:50 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
1:51 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
12:59 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13D/A
05/31/2024
5:37 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:34 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:33 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:43 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:44 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:46 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:47 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:14 PM
Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:18 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:03 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:30 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
5:10 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
04/01/2024
5:15 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
DOGE could send 6 AI stocks through the roof (Ad)

Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.

Click here to find out what DOGE's next move is.
03/26/2024
3:05 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:PHAT) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners